Atlas Trials

Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder

Clinical trial NCT03526354 · COMPLETED

Trial details

NCT number
NCT03526354
Sponsor
University of Massachusetts, Worcester
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective DisorderSubstance Use Disorders
Start date
2018-06-19
Primary completion
2024-02-29
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.